0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Radiopharmaceuticals for Diagnosis Market Research Report 2024
Published Date: September 2024
|
Report Code: QYRE-Auto-18S18151
Home | Market Reports | Health| Pharmacy
Global Radiopharmaceuticals for Diagnosis Market Research Report 2024
BUY CHAPTERS

Global Radiopharmaceuticals for Diagnosis Market Research Report 2024

Code: QYRE-Auto-18S18151
Report
September 2024
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Radiopharmaceuticals for Diagnosis Market

Diagnostic radiopharmaceuticals are a special class of drugs used in medical imaging diagnosis. These drugs contain radioactive isotopes that can locate and emit radiation signals in specific organs or tissues in the body. Through these signals, doctors can use nuclear medicine imaging equipment (such as single photon emission computed tomography (SPECT) and positron emission tomography (PET)) to detect and evaluate the presence and extent of various diseases, such as cancer, heart disease, thyroid dysfunction, brain disease, etc.
The global Radiopharmaceuticals for Diagnosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Radiopharmaceuticals for Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Radiopharmaceuticals for Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Radiopharmaceuticals for Diagnosis include Atom High-tech Co., Ltd., Shanghai Xinke Pharmaceutical Co., Ltd., Guangdong Xi'ai Pharmaceutical Co., Ltd., Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory, Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd., Chengdu Yunke Pharmaceutical Co., Ltd., Shanghai Atom Kexing Pharmaceutical Co., Ltd., Shenzhen Larven Bioengineering Technology Co., Ltd., Ningbo Jun'an Pharmaceutical Technology Co., Ltd., Beijing Zhibo High-tech Biotechnology Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Radiopharmaceuticals for Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceuticals for Diagnosis.
The Radiopharmaceuticals for Diagnosis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Radiopharmaceuticals for Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiopharmaceuticals for Diagnosis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Radiopharmaceuticals for Diagnosis Market Report

Report Metric Details
Report Name Radiopharmaceuticals for Diagnosis Market
Segment by Type
  • Technetium [99mTc] Dithiodithiocarbamate
  • Technetium [99mTc] Polymerized Albumin
  • Technetium [99mTc] Pentetate
  • Strontium [89Sr] Chloride
  • Iodine [125I] Sealed Seed Source
  • Sodium Iodide [131I]
  • Other
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Atom High-tech Co., Ltd., Shanghai Xinke Pharmaceutical Co., Ltd., Guangdong Xi'ai Pharmaceutical Co., Ltd., Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory, Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd., Chengdu Yunke Pharmaceutical Co., Ltd., Shanghai Atom Kexing Pharmaceutical Co., Ltd., Shenzhen Larven Bioengineering Technology Co., Ltd., Ningbo Jun'an Pharmaceutical Technology Co., Ltd., Beijing Zhibo High-tech Biotechnology Co., Ltd., Tianjin Said Biopharmaceutical Co., Ltd., Chengdu Zhonghe Gaotong Isotope Co., Ltd., Chengdu Xinke Pharmaceutical Co., Ltd., Jubilant Radiopharma, PDRadiopharma Inc., GE Healthcare Ltd, DOE IP, RadioMedix, Inc., Lantheus
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Radiopharmaceuticals for Diagnosis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Radiopharmaceuticals for Diagnosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Radiopharmaceuticals for Diagnosis Market report?

Ans: The main players in the Radiopharmaceuticals for Diagnosis Market are Atom High-tech Co., Ltd., Shanghai Xinke Pharmaceutical Co., Ltd., Guangdong Xi'ai Pharmaceutical Co., Ltd., Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory, Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd., Chengdu Yunke Pharmaceutical Co., Ltd., Shanghai Atom Kexing Pharmaceutical Co., Ltd., Shenzhen Larven Bioengineering Technology Co., Ltd., Ningbo Jun'an Pharmaceutical Technology Co., Ltd., Beijing Zhibo High-tech Biotechnology Co., Ltd., Tianjin Said Biopharmaceutical Co., Ltd., Chengdu Zhonghe Gaotong Isotope Co., Ltd., Chengdu Xinke Pharmaceutical Co., Ltd., Jubilant Radiopharma, PDRadiopharma Inc., GE Healthcare Ltd, DOE IP, RadioMedix, Inc., Lantheus

What are the Application segmentation covered in the Radiopharmaceuticals for Diagnosis Market report?

Ans: The Applications covered in the Radiopharmaceuticals for Diagnosis Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Radiopharmaceuticals for Diagnosis Market report?

Ans: The Types covered in the Radiopharmaceuticals for Diagnosis Market report are Technetium [99mTc] Dithiodithiocarbamate, Technetium [99mTc] Polymerized Albumin, Technetium [99mTc] Pentetate, Strontium [89Sr] Chloride, Iodine [125I] Sealed Seed Source, Sodium Iodide [131I], Other

Recommended Reports

Radiopharmaceutical Markets

Nuclear Medicine Equipment

Radioisotopes & Agents

1 Radiopharmaceuticals for Diagnosis Market Overview
1.1 Product Definition
1.2 Radiopharmaceuticals for Diagnosis by Type
1.2.1 Global Radiopharmaceuticals for Diagnosis Market Value Comparison by Type (2024-2030)
1.2.2 Technetium 99mTc Dithiodithiocarbamate
1.2.3 Technetium 99mTc Polymerized Albumin
1.2.4 Technetium 99mTc Pentetate
1.2.5 Strontium 89Sr Chloride
1.2.6 Iodine 125I Sealed Seed Source
1.2.7 Sodium Iodide 131I
1.2.8 Other
1.3 Radiopharmaceuticals for Diagnosis by Application
1.3.1 Global Radiopharmaceuticals for Diagnosis Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Radiopharmaceuticals for Diagnosis Market Size Estimates and Forecasts
1.4.1 Global Radiopharmaceuticals for Diagnosis Revenue 2019-2030
1.4.2 Global Radiopharmaceuticals for Diagnosis Sales 2019-2030
1.4.3 Global Radiopharmaceuticals for Diagnosis Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Radiopharmaceuticals for Diagnosis Market Competition by Manufacturers
2.1 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Manufacturers (2019-2024)
2.2 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Radiopharmaceuticals for Diagnosis Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Radiopharmaceuticals for Diagnosis, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Radiopharmaceuticals for Diagnosis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Radiopharmaceuticals for Diagnosis, Product Type & Application
2.7 Global Key Manufacturers of Radiopharmaceuticals for Diagnosis, Date of Enter into This Industry
2.8 Global Radiopharmaceuticals for Diagnosis Market Competitive Situation and Trends
2.8.1 Global Radiopharmaceuticals for Diagnosis Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Radiopharmaceuticals for Diagnosis Players Market Share by Revenue
2.8.3 Global Radiopharmaceuticals for Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Radiopharmaceuticals for Diagnosis Market Scenario by Region
3.1 Global Radiopharmaceuticals for Diagnosis Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Radiopharmaceuticals for Diagnosis Sales by Region: 2019-2030
3.2.1 Global Radiopharmaceuticals for Diagnosis Sales by Region: 2019-2024
3.2.2 Global Radiopharmaceuticals for Diagnosis Sales by Region: 2025-2030
3.3 Global Radiopharmaceuticals for Diagnosis Revenue by Region: 2019-2030
3.3.1 Global Radiopharmaceuticals for Diagnosis Revenue by Region: 2019-2024
3.3.2 Global Radiopharmaceuticals for Diagnosis Revenue by Region: 2025-2030
3.4 North America Radiopharmaceuticals for Diagnosis Market Facts & Figures by Country
3.4.1 North America Radiopharmaceuticals for Diagnosis Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Radiopharmaceuticals for Diagnosis Sales by Country (2019-2030)
3.4.3 North America Radiopharmaceuticals for Diagnosis Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Radiopharmaceuticals for Diagnosis Market Facts & Figures by Country
3.5.1 Europe Radiopharmaceuticals for Diagnosis Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Radiopharmaceuticals for Diagnosis Sales by Country (2019-2030)
3.5.3 Europe Radiopharmaceuticals for Diagnosis Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Radiopharmaceuticals for Diagnosis Market Facts & Figures by Region
3.6.1 Asia Pacific Radiopharmaceuticals for Diagnosis Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Radiopharmaceuticals for Diagnosis Sales by Region (2019-2030)
3.6.3 Asia Pacific Radiopharmaceuticals for Diagnosis Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Radiopharmaceuticals for Diagnosis Market Facts & Figures by Country
3.7.1 Latin America Radiopharmaceuticals for Diagnosis Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Radiopharmaceuticals for Diagnosis Sales by Country (2019-2030)
3.7.3 Latin America Radiopharmaceuticals for Diagnosis Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Radiopharmaceuticals for Diagnosis Market Facts & Figures by Country
3.8.1 Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Country (2019-2030)
3.8.3 Middle East and Africa Radiopharmaceuticals for Diagnosis Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Radiopharmaceuticals for Diagnosis Sales by Type (2019-2030)
4.1.1 Global Radiopharmaceuticals for Diagnosis Sales by Type (2019-2024)
4.1.2 Global Radiopharmaceuticals for Diagnosis Sales by Type (2025-2030)
4.1.3 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2019-2030)
4.2 Global Radiopharmaceuticals for Diagnosis Revenue by Type (2019-2030)
4.2.1 Global Radiopharmaceuticals for Diagnosis Revenue by Type (2019-2024)
4.2.2 Global Radiopharmaceuticals for Diagnosis Revenue by Type (2025-2030)
4.2.3 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2019-2030)
4.3 Global Radiopharmaceuticals for Diagnosis Price by Type (2019-2030)
5 Segment by Application
5.1 Global Radiopharmaceuticals for Diagnosis Sales by Application (2019-2030)
5.1.1 Global Radiopharmaceuticals for Diagnosis Sales by Application (2019-2024)
5.1.2 Global Radiopharmaceuticals for Diagnosis Sales by Application (2025-2030)
5.1.3 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2019-2030)
5.2 Global Radiopharmaceuticals for Diagnosis Revenue by Application (2019-2030)
5.2.1 Global Radiopharmaceuticals for Diagnosis Revenue by Application (2019-2024)
5.2.2 Global Radiopharmaceuticals for Diagnosis Revenue by Application (2025-2030)
5.2.3 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application (2019-2030)
5.3 Global Radiopharmaceuticals for Diagnosis Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Atom High-tech Co., Ltd.
6.1.1 Atom High-tech Co., Ltd. Company Information
6.1.2 Atom High-tech Co., Ltd. Description and Business Overview
6.1.3 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
6.1.5 Atom High-tech Co., Ltd. Recent Developments/Updates
6.2 Shanghai Xinke Pharmaceutical Co., Ltd.
6.2.1 Shanghai Xinke Pharmaceutical Co., Ltd. Company Information
6.2.2 Shanghai Xinke Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
6.2.5 Shanghai Xinke Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Guangdong Xi'ai Pharmaceutical Co., Ltd.
6.3.1 Guangdong Xi'ai Pharmaceutical Co., Ltd. Company Information
6.3.2 Guangdong Xi'ai Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
6.3.5 Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
6.4.1 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Company Information
6.4.2 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Description and Business Overview
6.4.3 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Portfolio
6.4.5 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Developments/Updates
6.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
6.5.1 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Company Information
6.5.2 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
6.5.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Chengdu Yunke Pharmaceutical Co., Ltd.
6.6.1 Chengdu Yunke Pharmaceutical Co., Ltd. Company Information
6.6.2 Chengdu Yunke Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
6.6.5 Chengdu Yunke Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Shanghai Atom Kexing Pharmaceutical Co., Ltd.
6.7.1 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Company Information
6.7.2 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
6.7.5 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Shenzhen Larven Bioengineering Technology Co., Ltd.
6.8.1 Shenzhen Larven Bioengineering Technology Co., Ltd. Company Information
6.8.2 Shenzhen Larven Bioengineering Technology Co., Ltd. Description and Business Overview
6.8.3 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
6.8.5 Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Developments/Updates
6.9 Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
6.9.1 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Company Information
6.9.2 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Description and Business Overview
6.9.3 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
6.9.5 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Developments/Updates
6.10 Beijing Zhibo High-tech Biotechnology Co., Ltd.
6.10.1 Beijing Zhibo High-tech Biotechnology Co., Ltd. Company Information
6.10.2 Beijing Zhibo High-tech Biotechnology Co., Ltd. Description and Business Overview
6.10.3 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
6.10.5 Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Developments/Updates
6.11 Tianjin Said Biopharmaceutical Co., Ltd.
6.11.1 Tianjin Said Biopharmaceutical Co., Ltd. Company Information
6.11.2 Tianjin Said Biopharmaceutical Co., Ltd. Description and Business Overview
6.11.3 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
6.11.5 Tianjin Said Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Chengdu Zhonghe Gaotong Isotope Co., Ltd.
6.12.1 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Company Information
6.12.2 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Description and Business Overview
6.12.3 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
6.12.5 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Developments/Updates
6.13 Chengdu Xinke Pharmaceutical Co., Ltd.
6.13.1 Chengdu Xinke Pharmaceutical Co., Ltd. Company Information
6.13.2 Chengdu Xinke Pharmaceutical Co., Ltd. Description and Business Overview
6.13.3 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
6.13.5 Chengdu Xinke Pharmaceutical Co., Ltd. Recent Developments/Updates
6.14 Jubilant Radiopharma
6.14.1 Jubilant Radiopharma Company Information
6.14.2 Jubilant Radiopharma Description and Business Overview
6.14.3 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Portfolio
6.14.5 Jubilant Radiopharma Recent Developments/Updates
6.15 PDRadiopharma Inc.
6.15.1 PDRadiopharma Inc. Company Information
6.15.2 PDRadiopharma Inc. Description and Business Overview
6.15.3 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2019-2024)
6.15.4 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Portfolio
6.15.5 PDRadiopharma Inc. Recent Developments/Updates
6.16 GE Healthcare Ltd
6.16.1 GE Healthcare Ltd Company Information
6.16.2 GE Healthcare Ltd Description and Business Overview
6.16.3 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2019-2024)
6.16.4 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Portfolio
6.16.5 GE Healthcare Ltd Recent Developments/Updates
6.17 DOE IP
6.17.1 DOE IP Company Information
6.17.2 DOE IP Description and Business Overview
6.17.3 DOE IP Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2019-2024)
6.17.4 DOE IP Radiopharmaceuticals for Diagnosis Product Portfolio
6.17.5 DOE IP Recent Developments/Updates
6.18 RadioMedix, Inc.
6.18.1 RadioMedix, Inc. Company Information
6.18.2 RadioMedix, Inc. Description and Business Overview
6.18.3 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2019-2024)
6.18.4 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product Portfolio
6.18.5 RadioMedix, Inc. Recent Developments/Updates
6.19 Lantheus
6.19.1 Lantheus Company Information
6.19.2 Lantheus Description and Business Overview
6.19.3 Lantheus Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Lantheus Radiopharmaceuticals for Diagnosis Product Portfolio
6.19.5 Lantheus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Radiopharmaceuticals for Diagnosis Industry Chain Analysis
7.2 Radiopharmaceuticals for Diagnosis Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Radiopharmaceuticals for Diagnosis Production Mode & Process
7.4 Radiopharmaceuticals for Diagnosis Sales and Marketing
7.4.1 Radiopharmaceuticals for Diagnosis Sales Channels
7.4.2 Radiopharmaceuticals for Diagnosis Distributors
7.5 Radiopharmaceuticals for Diagnosis Customers
8 Radiopharmaceuticals for Diagnosis Market Dynamics
8.1 Radiopharmaceuticals for Diagnosis Industry Trends
8.2 Radiopharmaceuticals for Diagnosis Market Drivers
8.3 Radiopharmaceuticals for Diagnosis Market Challenges
8.4 Radiopharmaceuticals for Diagnosis Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Radiopharmaceuticals for Diagnosis Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Radiopharmaceuticals for Diagnosis Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Radiopharmaceuticals for Diagnosis Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Radiopharmaceuticals for Diagnosis Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Radiopharmaceuticals for Diagnosis Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Radiopharmaceuticals for Diagnosis Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Radiopharmaceuticals for Diagnosis Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Radiopharmaceuticals for Diagnosis, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Radiopharmaceuticals for Diagnosis, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Radiopharmaceuticals for Diagnosis, Product Type & Application
 Table 12. Global Key Manufacturers of Radiopharmaceuticals for Diagnosis, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Radiopharmaceuticals for Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals for Diagnosis as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Radiopharmaceuticals for Diagnosis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Radiopharmaceuticals for Diagnosis Sales by Region (2019-2024) & (K Units)
 Table 18. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Region (2019-2024)
 Table 19. Global Radiopharmaceuticals for Diagnosis Sales by Region (2025-2030) & (K Units)
 Table 20. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Region (2025-2030)
 Table 21. Global Radiopharmaceuticals for Diagnosis Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Region (2019-2024)
 Table 23. Global Radiopharmaceuticals for Diagnosis Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Region (2025-2030)
 Table 25. North America Radiopharmaceuticals for Diagnosis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Radiopharmaceuticals for Diagnosis Sales by Country (2019-2024) & (K Units)
 Table 27. North America Radiopharmaceuticals for Diagnosis Sales by Country (2025-2030) & (K Units)
 Table 28. North America Radiopharmaceuticals for Diagnosis Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Radiopharmaceuticals for Diagnosis Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Radiopharmaceuticals for Diagnosis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Radiopharmaceuticals for Diagnosis Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Radiopharmaceuticals for Diagnosis Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Radiopharmaceuticals for Diagnosis Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Radiopharmaceuticals for Diagnosis Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Radiopharmaceuticals for Diagnosis Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Radiopharmaceuticals for Diagnosis Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Radiopharmaceuticals for Diagnosis Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Radiopharmaceuticals for Diagnosis Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Radiopharmaceuticals for Diagnosis Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Radiopharmaceuticals for Diagnosis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Radiopharmaceuticals for Diagnosis Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Radiopharmaceuticals for Diagnosis Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Radiopharmaceuticals for Diagnosis Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Radiopharmaceuticals for Diagnosis Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Radiopharmaceuticals for Diagnosis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Radiopharmaceuticals for Diagnosis Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Radiopharmaceuticals for Diagnosis Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Radiopharmaceuticals for Diagnosis Sales (K Units) by Type (2019-2024)
 Table 51. Global Radiopharmaceuticals for Diagnosis Sales (K Units) by Type (2025-2030)
 Table 52. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2019-2024)
 Table 53. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2025-2030)
 Table 54. Global Radiopharmaceuticals for Diagnosis Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Radiopharmaceuticals for Diagnosis Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2019-2024)
 Table 57. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2025-2030)
 Table 58. Global Radiopharmaceuticals for Diagnosis Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Radiopharmaceuticals for Diagnosis Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Radiopharmaceuticals for Diagnosis Sales (K Units) by Application (2019-2024)
 Table 61. Global Radiopharmaceuticals for Diagnosis Sales (K Units) by Application (2025-2030)
 Table 62. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2019-2024)
 Table 63. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2025-2030)
 Table 64. Global Radiopharmaceuticals for Diagnosis Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Radiopharmaceuticals for Diagnosis Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application (2019-2024)
 Table 67. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application (2025-2030)
 Table 68. Global Radiopharmaceuticals for Diagnosis Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Radiopharmaceuticals for Diagnosis Price (US$/Unit) by Application (2025-2030)
 Table 70. Atom High-tech Co., Ltd. Company Information
 Table 71. Atom High-tech Co., Ltd. Description and Business Overview
 Table 72. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product
 Table 74. Atom High-tech Co., Ltd. Recent Developments/Updates
 Table 75. Shanghai Xinke Pharmaceutical Co., Ltd. Company Information
 Table 76. Shanghai Xinke Pharmaceutical Co., Ltd. Description and Business Overview
 Table 77. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product
 Table 79. Shanghai Xinke Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 80. Guangdong Xi'ai Pharmaceutical Co., Ltd. Company Information
 Table 81. Guangdong Xi'ai Pharmaceutical Co., Ltd. Description and Business Overview
 Table 82. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product
 Table 84. Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 85. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Company Information
 Table 86. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Description and Business Overview
 Table 87. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product
 Table 89. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Developments/Updates
 Table 90. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Company Information
 Table 91. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Description and Business Overview
 Table 92. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product
 Table 94. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 95. Chengdu Yunke Pharmaceutical Co., Ltd. Company Information
 Table 96. Chengdu Yunke Pharmaceutical Co., Ltd. Description and Business Overview
 Table 97. Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product
 Table 99. Chengdu Yunke Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 100. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Company Information
 Table 101. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Description and Business Overview
 Table 102. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product
 Table 104. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 105. Shenzhen Larven Bioengineering Technology Co., Ltd. Company Information
 Table 106. Shenzhen Larven Bioengineering Technology Co., Ltd. Description and Business Overview
 Table 107. Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product
 Table 109. Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Developments/Updates
 Table 110. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Company Information
 Table 111. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Description and Business Overview
 Table 112. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product
 Table 114. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Developments/Updates
 Table 115. Beijing Zhibo High-tech Biotechnology Co., Ltd. Company Information
 Table 116. Beijing Zhibo High-tech Biotechnology Co., Ltd. Description and Business Overview
 Table 117. Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product
 Table 119. Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Developments/Updates
 Table 120. Tianjin Said Biopharmaceutical Co., Ltd. Company Information
 Table 121. Tianjin Said Biopharmaceutical Co., Ltd. Description and Business Overview
 Table 122. Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product
 Table 124. Tianjin Said Biopharmaceutical Co., Ltd. Recent Developments/Updates
 Table 125. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Company Information
 Table 126. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Description and Business Overview
 Table 127. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product
 Table 129. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Developments/Updates
 Table 130. Chengdu Xinke Pharmaceutical Co., Ltd. Company Information
 Table 131. Chengdu Xinke Pharmaceutical Co., Ltd. Description and Business Overview
 Table 132. Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product
 Table 134. Chengdu Xinke Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 135. Jubilant Radiopharma Company Information
 Table 136. Jubilant Radiopharma Description and Business Overview
 Table 137. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product
 Table 139. Jubilant Radiopharma Recent Developments/Updates
 Table 140. PDRadiopharma Inc. Company Information
 Table 141. PDRadiopharma Inc. Description and Business Overview
 Table 142. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product
 Table 144. PDRadiopharma Inc. Recent Developments/Updates
 Table 145. GE Healthcare Ltd Company Information
 Table 146. GE Healthcare Ltd Description and Business Overview
 Table 147. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 148. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product
 Table 149. GE Healthcare Ltd Recent Developments/Updates
 Table 150. DOE IP Company Information
 Table 151. DOE IP Description and Business Overview
 Table 152. DOE IP Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 153. DOE IP Radiopharmaceuticals for Diagnosis Product
 Table 154. DOE IP Recent Developments/Updates
 Table 155. RadioMedix, Inc. Company Information
 Table 156. RadioMedix, Inc. Description and Business Overview
 Table 157. RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 158. RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product
 Table 159. RadioMedix, Inc. Recent Developments/Updates
 Table 160. Lantheus Company Information
 Table 161. Lantheus Description and Business Overview
 Table 162. Lantheus Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 163. Lantheus Radiopharmaceuticals for Diagnosis Product
 Table 164. Lantheus Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Radiopharmaceuticals for Diagnosis Distributors List
 Table 168. Radiopharmaceuticals for Diagnosis Customers List
 Table 169. Radiopharmaceuticals for Diagnosis Market Trends
 Table 170. Radiopharmaceuticals for Diagnosis Market Drivers
 Table 171. Radiopharmaceuticals for Diagnosis Market Challenges
 Table 172. Radiopharmaceuticals for Diagnosis Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Radiopharmaceuticals for Diagnosis
 Figure 2. Global Radiopharmaceuticals for Diagnosis Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Radiopharmaceuticals for Diagnosis Market Share by Type: 2023 & 2030
 Figure 4. Technetium 99mTc Dithiodithiocarbamate Product Picture
 Figure 5. Technetium 99mTc Polymerized Albumin Product Picture
 Figure 6. Technetium 99mTc Pentetate Product Picture
 Figure 7. Strontium 89Sr Chloride Product Picture
 Figure 8. Iodine 125I Sealed Seed Source Product Picture
 Figure 9. Sodium Iodide 131I Product Picture
 Figure 10. Other Product Picture
 Figure 11. Global Radiopharmaceuticals for Diagnosis Market Value by Application (2024-2030) & (US$ Million)
 Figure 12. Global Radiopharmaceuticals for Diagnosis Market Share by Application: 2023 & 2030
 Figure 13. Hospital
 Figure 14. Clinic
 Figure 15. Other
 Figure 16. Global Radiopharmaceuticals for Diagnosis Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 17. Global Radiopharmaceuticals for Diagnosis Market Size (2019-2030) & (US$ Million)
 Figure 18. Global Radiopharmaceuticals for Diagnosis Sales (2019-2030) & (K Units)
 Figure 19. Global Radiopharmaceuticals for Diagnosis Average Price (US$/Unit) & (2019-2030)
 Figure 20. Radiopharmaceuticals for Diagnosis Report Years Considered
 Figure 21. Radiopharmaceuticals for Diagnosis Sales Share by Manufacturers in 2023
 Figure 22. Global Radiopharmaceuticals for Diagnosis Revenue Share by Manufacturers in 2023
 Figure 23. Global 5 and 10 Largest Radiopharmaceuticals for Diagnosis Players: Market Share by Revenue in Radiopharmaceuticals for Diagnosis in 2023
 Figure 24. Radiopharmaceuticals for Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 25. Global Radiopharmaceuticals for Diagnosis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 26. North America Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2019-2030)
 Figure 27. North America Radiopharmaceuticals for Diagnosis Revenue Market Share by Country (2019-2030)
 Figure 28. United States Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Canada Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Europe Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2019-2030)
 Figure 31. Europe Radiopharmaceuticals for Diagnosis Revenue Market Share by Country (2019-2030)
 Figure 32. Germany Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. France Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. U.K. Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Italy Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Russia Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Asia Pacific Radiopharmaceuticals for Diagnosis Sales Market Share by Region (2019-2030)
 Figure 38. Asia Pacific Radiopharmaceuticals for Diagnosis Revenue Market Share by Region (2019-2030)
 Figure 39. China Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Japan Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. South Korea Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. India Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Australia Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. China Taiwan Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Southeast Asia Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Latin America Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2019-2030)
 Figure 47. Mexico Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Brazil Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Argentina Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Colombia Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2019-2030)
 Figure 52. Middle East and Africa Radiopharmaceuticals for Diagnosis Revenue Market Share by Country (2019-2030)
 Figure 53. Turkey Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Saudi Arabia Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 55. UAE Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 56. Global Sales Market Share of Radiopharmaceuticals for Diagnosis by Type (2019-2030)
 Figure 57. Global Revenue Market Share of Radiopharmaceuticals for Diagnosis by Type (2019-2030)
 Figure 58. Global Radiopharmaceuticals for Diagnosis Price (US$/Unit) by Type (2019-2030)
 Figure 59. Global Sales Market Share of Radiopharmaceuticals for Diagnosis by Application (2019-2030)
 Figure 60. Global Revenue Market Share of Radiopharmaceuticals for Diagnosis by Application (2019-2030)
 Figure 61. Global Radiopharmaceuticals for Diagnosis Price (US$/Unit) by Application (2019-2030)
 Figure 62. Radiopharmaceuticals for Diagnosis Value Chain
 Figure 63. Radiopharmaceuticals for Diagnosis Production Process
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart